Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works

Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,549 · see citing works

The p53 tumour suppressor gene

Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785 · see citing works

Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins

Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,046 · see citing works

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,443 · see citing works

A rapid micrqpreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,337 · see citing works

Fos and jun: The AP-1 connection

Curran, T., & Franza, B. R. (1988) · Cell · doi:10.1016/0092-8674(88)90024-4 · Cited by 1,595 · see citing works

Regulation of Inducible and Tissue-Specific Gene Expression

Maniatis, T., Goodbourn, S., & Fischer, J. A. (1987) · Science · doi:10.1126/science.3296191 · Cited by 1,553 · see citing works

The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter

Dynan, W. S., & Tjian, R. (1983) · Cell · doi:10.1016/0092-8674(83)90210-6 · Cited by 1,445 · see citing works

Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP

Imagawa, M. (1987) · Cell · doi:10.1016/0092-8674(87)90152-8 · Cited by 1,384 · see citing works

Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins

Dynan, W. S., & Tjian, R. (1985) · Nature · doi:10.1038/316774a0 · Cited by 1,251 · see citing works

Apoptosis And Programmed Cell Death In Immunity

Cohen, J., Duke, R. C., Fadok, V. A., & Sellins, K. S. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001411 · Cited by 1,112 · see citing works

Identification of p53 as a Sequence-Specific DNA-Binding Protein

Kern, S. E., Kinzler, K. W., Bruskin, A. M., Jarosz, D., Friedman, P. N., Prives, C. L., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085 · see citing works

Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

Gannon, J., Greaves, R. F., Iggo, R. D., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 970 · see citing works

Positive and negative regulation of transcription in vitro: Enhancer-binding protein AP-2 is inhibited by SV40 T antigen

Mitchell, P. J., Wang, C. I., & Tjian, R. (1987) · Cell · doi:10.1016/0092-8674(87)90512-5 · Cited by 904 · see citing works

Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M., & Taylor, D. R. (1990) · Nature · doi:10.1038/343076a0 · Cited by 887 · see citing works

Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor Cells

Koury, M. J., & Bondurant, M. C. (1990) · Science · doi:10.1126/science.2326648 · Cited by 841 · see citing works

Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro

Jones, K. A., Yamamoto, K. R., & Tjian, R. (1985) · Cell · doi:10.1016/0092-8674(85)90113-8 · Cited by 806 · see citing works

Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin

Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y., Miyazono, K., Urabe, A., & Takaku, F. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400219 · Cited by 784 · see citing works

Activation of the AIDS Retrovirus Promoter by the Cellular Transcription Factor, Sp1

Jones, K. A., Kadonaga, J. T., Luciw, P. A., & Tjian, R. (1986) · Science · doi:10.1126/science.3008338 · Cited by 702 · see citing works

A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs

Santoro, C., Mermod, N., Andrews, P., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 696 · see citing works

Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

Griffin, G. E., Leung, K., Folks, T. M., Kunkel, S. L., & Nabel, G. J. (1989) · Nature · doi:10.1038/339070a0 · Cited by 583 · see citing works

Synergistic activation by the glutamine-rich domains of human transcription factor Sp1

Courey, A. J., Holtzman, D. A., Jackson, S. P., & Tjian, R. (1989) · Cell · doi:10.1016/0092-8674(89)90606-5 · Cited by 524 · see citing works

Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

Reich, N. C., & Levine, A. J. (1984) · Nature · doi:10.1038/308199a0 · Cited by 517 · see citing works

Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression

Banks, L., Matlashewski, G., & Crawford, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09919.x · Cited by 505 · see citing works

Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism.Preprint

Pascal, E., & Tjian, R. (1991) · Genes & Development · doi:10.1101/gad.5.9.1646 · Cited by 441 · see citing works

Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication

Bargonetti, J., Friedman, P. N., Kern, S. E., Vogelstein, B., & Prives, C. L. (1991) · Cell · doi:10.1016/0092-8674(91)90560-l · Cited by 367 · see citing works

Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription

Li, R., Knight, J. D., Jackson, S. P., Tjian, R., & Botchan, M. R. (1991) · Cell · doi:10.1016/0092-8674(91)90467-d · Cited by 303 · see citing works

Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene.

Ueda, K., Pastan, I. H., & Gottesman, M. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45397-5 · Cited by 290 · see citing works

Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.

Mercer, W. E., Nelson, D., DeLeo, A. B., Old, L. J., & Baserga, R. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6309 · Cited by 255 · see citing works

The Retinoblastoma Gene Product Regulates Sp1-Mediated Transcription

Kim, S. J., Onwuta, U. S., Lee, Y. I., Li, R., Botchan, M. R., & Robbins, P. D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2455 · Cited by 246 · see citing works

Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies.

Mercer, W. E., Avignolo, C., & Baserga, R. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.2.276 · Cited by 216 · see citing works

Frequent mutations in the p53 gene in human myeloid leukemia cell lines

Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y., & Hirai, H. (1992) · Blood · doi:10.1182/blood.v79.9.2378.2378 · Cited by 213 · see citing works

The p53 tumor suppressor protein, a modulator of cell proliferation.

Ullrich, S. J., Anderson, C. W., Mercer, W. E., & Appella, E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49524-0 · Cited by 168 · see citing works

Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells.

Sherman, M. L., Stone, R. M., Datta, R., Bernstein, S. H., & Kufe, D. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39769-8 · Cited by 166 · see citing works

Role of protein kinase C and the Na+/H+ antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3.

Rajotte, D., Haddad, P. S., Haman, A., Cragoe, E. J., & Hoang, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50188-0 · Cited by 152 · see citing works

Programmed cell death (apoptosis) in hematopoiesis.

Mj, K. (1992) · PubMed · Cited by 149 · see citing works

Oligomerization of oncoprotein p53

Kraiss, S., Quaiser, A., Oren, M., & Montenarh, M. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4737-4744.1988 · Cited by 147 · see citing works

Cooperative interactions between transcription factors Sp1 and OTF-1.

Janson, L., & Pettersson, U. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4732 · Cited by 115 · see citing works

A DNA binding domain is contained in the C-terminus ofwild typep53 protein

Foord, O., Bhattacharya, P., Reich, Z., & Rotter, V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.19.5191 · Cited by 111 · see citing works

K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation

Yu, G., Smithgall, T. E., & Glazer, R. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81796-3 · Cited by 100 · see citing works

Regulation of c-jun expression and AP-1 enhancer activity by granulocyte-macrophage colony-stimulating factor.

Adunyah, S. E., Unlap, T., Wagner, F., & Kraft, A. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67647-7 · Cited by 66 · see citing works

Altered binding of human histone gene transcription factors during the shutdown of proliferation and onset of differentiation in HL-60 cells.

Stein, G., Lian, J. B., Stein, J. L., Briggs, R. C., Shalhoub, V., Wright, K., Pauli, U., & van Wijnen, A. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.1865 · Cited by 57 · see citing works

Increased Expression and DNA-Binding Activity of Transcription Factor Sp1 in Doxorubicin-Resistant HL-60 Leukemia Cells

Borellini, F., Aquino, A., Josephs, S. F., & Glazer, R. I. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5541 · Cited by 44 · see citing works

Increased DNA binding and transcriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene

Borellini, F., He, Y., Aquino, A., Yu, G., Josephs, S. F., & Glazer, R. I. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98486-3 · Cited by 38 · see citing works

Regulation of jun and fos gene expression in human monocytes by the macrophage colony-stimulating factor.

Nakamura, T., Datta, R., Kharbanda, S. M., & Kufe, D. W. (1991) · PubMed · Cited by 35 · see citing works

Induction of genes for transcription factors by normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells.

Shabo, Y., Lotem, J., & Sachs, L. (1990) · PubMed · Cited by 21 · see citing works

Protein-protein interactions in high molecular weight forms of the transformation-related phosphoprotein p53

Kraiss, S., Lorenz, A., & Montenarh, M. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90227-5 · Cited by 13 · see citing works

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,338 · see citing works

p53 mutations in cancer

Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647 · see citing works

Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer

Black, A. R., Black, J. D., & Azizkhan‐Clifford, J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1111 · Cited by 1,049 · see citing works

Census and evaluation of p53 target genes

Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971 · see citing works

Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression

Owen‐Schaub, L. B., Zhang, W. K., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A., Zhang, W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 731 · see citing works

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

Mirza, A., McGuirk, M., Hockenberry, T., Wu, Q. J., Ashar, H. R., Black, S., Wen, S. F., Wang, L., Kirschmeier, P. T., Bishop, W. R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205353 · Cited by 530 · see citing works

p53 in growth control and neoplasia

Gottlieb, T. M., & Oren, M. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00019-c · Cited by 481 · see citing works

Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions

Safe, S. H. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)62006-5 · Cited by 418 · see citing works

The von Hippel-Lindau Tumor Suppressor Gene Product Interacts with Sp1 To Repress Vascular Endothelial Growth Factor Promoter Activity

Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Karumanchi, S. A., & Sukhatme, V. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5629 · Cited by 337 · see citing works

Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.

Wang, L., Wei, D., Huang, S., Peng, Z., Le, X., Wu, T. T., Yao, J. C., Ajani, J. A., & Xie, K. (2003) · PubMed · Cited by 334 · see citing works

COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective

Harris, C. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1187 · Cited by 284 · see citing works

Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells

Xu, D., Wang, Q., Gruber, A., Björkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K. G., & Pisa, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203890 · Cited by 257 · see citing works

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.

Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929 · Cited by 237 · see citing works

Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.

Zhang, L., Yu, D., Hu, M., Xiong, S., Lang, A., Ellis, L. M., & Pollock, R. E. (2000) · PubMed · Cited by 230 · see citing works

The Tumor Suppressor p53 and Histone Deacetylase 1 Are Antagonistic Regulators of the Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1 Gene

Egger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2669-2679.2003 · Cited by 214 · see citing works

Modulation of Transcription Factor Sp1 by cAMP-dependent Protein Kinase

Rohlff, C., Ahmad, S., Borellini, F., Lei, J., & Glazer, R. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21137 · Cited by 206 · see citing works

Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric Cancer

Yao, J. C., Wang, L., Wei, D., Gong, W., Hassan, M. M., Wu, T., Mansfield, P. F., Ajani, J. A., & Xie, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0628 · Cited by 199 · see citing works

Activation of the cryptic DNA binding function of mutant forms of p53

Hupp, T. R., Meek, D. W., Midgley, C., & Lane, D. P. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.14.3167 · Cited by 189 · see citing works

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

Mirza, A., Wu, Q. J., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P. T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183 · see citing works

Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53

Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Muñoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., & Deb, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6009 · Cited by 181 · see citing works

p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents

Thottassery, J. V., Zambetti, G. P., Arimori, K., Schuetz, E. G., & Schuetz, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11037 · Cited by 161 · see citing works

DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms

Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 162 · see citing works

Sp1 Plays a Critical Role in the Transcriptional Activation of the Human Cyclin-dependent Kinase Inhibitor p21 Gene by the p53 Tumor Suppressor Protein

Koutsodontis, G., Tentes, I. K., Papakosta, P., Moustakas, A., & Kardassis, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104130200 · Cited by 159 · see citing works

p53 Regulates Insulin-Like Growth Factor-I (IGF-I) Receptor Expression and IGF-I-Induced Tyrosine Phosphorylation in an Osteosarcoma Cell Line: Interaction between p53 and Sp1

Ohlsson, C., Kley, N., Werner, H., & LeRoith, D. (1998) · Endocrinology · doi:10.1210/endo.139.3.5832 · Cited by 157 · see citing works

Steroidogenic Factor 1 (SF-1) and SP1 Are Required for Regulation of Bovine CYP11A Gene Expression in Bovine Luteal Cells and Adrenal Y1 Cells

Liu, Z., & Simpson, E. R. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.2.9890 · Cited by 156 · see citing works

Inhibition of DNA Topoisomerase IIα Gene Expression by the p53 Tumor Suppressor

Wang, Q., Zambetti, G. P., & Suttle, D. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.389 · Cited by 149 · see citing works

Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.

Webster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 149 · see citing works

Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression

Scian, M. J., Stagliano, K. E., Anderson, M. A. E., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., & Deb, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10097-10110.2005 · Cited by 149 · see citing works

p53 Down-regulates Human Matrix Metalloproteinase-1 (Collagenase-1) Gene Expression

Sun, Y., Sun, Y., Wenger, L., Rutter, J. L., Brinckerhoff, C., & Cheung, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11535 · Cited by 143 · see citing works

Nuclear Receptor-Mediated Transactivation Through Interaction with Sp Proteins

Safe, S. H., & Kim, K. (2004) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(04)77001-4 · Cited by 143 · see citing works

Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I–transformed cells

Sinha-Datta, U., Horikawa, I., Michishita, E., Datta, A., Sigler-Nicot, J. C., Brown, M., Kazanji, M., Barrett, J. C., & Nicot, C. (2004) · Blood · doi:10.1182/blood-2003-12-4251 · Cited by 126 · see citing works

Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter

Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120 · see citing works

p53: A Cell Cycle Regulator Activated by DNA Damage

Selivanova, G., & Wiman, K. G. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60253-5 · Cited by 118 · see citing works

Modulation of Gene Expression by Tumor-Derived p53 Mutants

Scian, M. J., Stagliano, K. E., Ellis, M. A., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., & Deb, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1568 · Cited by 117 · see citing works

The Cyclin A1-CDK2 Complex Regulates DNA Double-Strand Break Repair

Müller‐Tidow, C., Ji, P., Diederichs, S., Potratz, J. C., Bäumer, N., Köhler, G., Cauvet, T., Choudary, C., van der Meer, T., Chan, W. Y. I., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8917-8928.2004 · Cited by 115 · see citing works

Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage

Zaky, A., Busso, C., Izumi, T., Chattopadhyay, R., Bassiouny, A., Mitra, S., & Bhakat, K. K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1173 · Cited by 111 · see citing works

p53 Regulates Caveolin Gene Transcription, Cell Cholesterol, and Growth by a Novel Mechanism

Bist, A., Fielding, C. J., & Fielding, P. E. (2000) · Biochemistry · doi:10.1021/bi991721h · Cited by 104 · see citing works

Functional and Physical Interaction between p53 and BZLF1: Implications for Epstein-Barr Virus Latency

Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929-1938.1994 · Cited by 104 · see citing works

Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.

Zhang, L., Kashanchi, F., Zhan, Q., Zhan, S., Brady, J. N., Fornace, A. J., Seth, P. K., & Helman, L. J. (1996) · PubMed · Cited by 102 · see citing works

p53 and Sp1 Interact and Cooperate in the Tumor Necrosis Factor-induced Transcriptional Activation of the HIV-1 Long Terminal Repeat

Gualberto, A., & Baldwin, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19680 · Cited by 101 · see citing works

The (patho)physiological functions of the MRP family

Renes, J., de Vries, E. G. E., Jansen, P. L. M., & Müller, M. M. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0156 · Cited by 100 · see citing works

Sp1 Is a Critical Regulator of the Wilms' tumor-1 Gene

Cohen, H. T., Bossone, S., Zhu, G., McDonald, G. A., & Sukhatme, V. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2901 · Cited by 100 · see citing works

ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter

Yan, C., Wang, H., & Boyd, D. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112069200 · Cited by 96 · see citing works

Wild Type and Mutant p53 Differentially Regulate the Gene Expression of Human Collagenase-3 (hMMP-13)

Sun, Y., Cheung, J. M., Martel‐Pelletier, J., Pelletier, J. P., Wenger, L., Altman, R. D., Howell, D. S., & Cheung, H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11327 · Cited by 95 · see citing works

p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor.

Bocangel, D., Sengupta, S., MITRA, S. P., & Bhakat, K. K. (2009) · PubMed · Cited by 94 · see citing works

Sp1-Mediated Transcription of the Werner Helicase Gene Is Modulated by Rb and p53

Yamabe, Y., Shimamoto, A., Goto, M., Yokota, J., Sugawara, M., & Furuichi, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6191 · Cited by 91 · see citing works

The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication

Duan, L., Ozaki, I., Oakes, J. W., Taylor, J. P., Khalili, K., & Pomerantz, R. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4302-4313.1994 · Cited by 91 · see citing works

Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis

Ozbun, M. A., & Butel, J. S. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60252-3 · Cited by 89 · see citing works

A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage

Yang, J. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.6.1117 · Cited by 86 · see citing works

The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX Promoter

Thornborrow, E. C., & Manfredi, J. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011643200 · Cited by 85 · see citing works

Regulation of Sp1 by cell cycle related proteins

Tapias, A., Ciudad, C. J., Roninson, I. B., & Noé, V. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6671 · Cited by 82 · see citing works

A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening

Gunther, M., Laithier, M., & Brison, O. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007177623283 · Cited by 81 · see citing works

Role of Sp1 in cAMP-dependent Transcriptional Regulation of the Bovine CYP11A Gene

Ahlgren, R., Suske, G., Waterman, M. R., & Lund, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19422 · Cited by 78 · see citing works

p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter

Pietrzak, M., & Puzianowska‐Kuźnicka, M. (2008) · Biological Chemistry · doi:10.1515/bc.2008.039 · Cited by 74 · see citing works

The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene

Duriez, C., Falette, N., Audoynaud, C., Moyret-Lalle, C., Bensaad, K., Courtois, S., Wang, Q., Soussi, T., & Puisieux, A. (2002) · Gene · doi:10.1016/s0378-1119(01)00825-3 · Cited by 73 · see citing works

Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression

Liu, Z., & R. Simpson, E. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00036-2 · Cited by 71 · see citing works

Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through an inverted CACCC motif and regulates promoter activity in cooperation with Ets1.

Dittmer, J., Gégonne, A., Gitlin, S. D., Ghysdael, J., & Brady, J. N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31821-5 · Cited by 71 · see citing works

The Gene Encoding p202, an Interferon-inducible Negative Regulator of the p53 Tumor Suppressor, Is a Target of p53-mediated Transcriptional Repression

D’Souza, S., Xin, H., Walter, S., & Choubey, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007155200 · Cited by 71 · see citing works

DNA Damage-induced Down-regulation of Human Cdc25C and Cdc2 Is Mediated by Cooperation between p53 and Maintenance DNA (Cytosine-5) Methyltransferase 1

Gac, G. L., Estève, P., Férec, C., & Pradhan, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603724200 · Cited by 70 · see citing works

P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3

Zerrouqi, A., Pyrzynska, B., Febbraio, M., Brat, D. J., & Van Meir, E. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38596 · Cited by 70 · see citing works

Mutant p53 Forms a Complex with Sp1 on HIV-LTR DNA

Chicas, A., Molina, P. E., & Bargonetti, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3965 · Cited by 69 · see citing works

Regulation of multidrug resistance through the cAMP and EGF signalling pathways

Rohlff, C., & Glazer, R. I. (1995) · Cellular Signalling · doi:10.1016/0898-6568(95)00018-k · Cited by 69 · see citing works

Wild Type p53 Stimulates Expression from the Human Multidrug Resistance Promoter in a p53-negative Cell Line

Goldsmith, M. E., Gudas, J. M., Schneider, E., & Cowan, K. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1894 · Cited by 69 · see citing works

Transcriptional Regulation of the Human DNA Polymerase δ Catalytic Subunit Gene POLD1 by p53 Tumor Suppressor and Sp1

Li, B., & Lee, M. Y. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101167200 · Cited by 65 · see citing works

p53 Homologue p63 Represses Epidermal Growth Factor Receptor Expression

Nishi, H., Senoo, M., Nishi, K., Murphy, B., Rikiyama, T., Matsumura, Y., Habu, S., & Johnson, A. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101241200 · Cited by 65 · see citing works

Infrequent mutations of the p53 gene in pulmonary carcinoid tumors.

Lohmann, D. R., FESSELER, B., Pütz, B., Reich, U., Böhm, J., Präuer, H. W., Wünsch, P. H., & Höfler, H. (1993) · PubMed · Cited by 65 · see citing works

Response of heat shock element within the human HSP70 promoter to mutated p53 genes.

Tsutsumi‐Ishii, Y., Tadokoro, K., Hanaoka, F., & Tsuchida, N. (1995) · PubMed · Cited by 64 · see citing works

Induction of p53-Dependent, Insulin-Like Growth Factor-Binding Protein-3-Mediated Apoptosis in Glioblastoma Multiforme Cells by a Protein Kinase Cα Antisense Oligonucleotide

Shen, L., Dean, N. M., & Glazer, R. I. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12039-1 · Cited by 64 · see citing works

Lead Exposure in Pheochromocytoma (PC12) Cells Alters Neural Differentiation and Sp1 DNA-Binding

Crumpton, T. L., Atkins, D. S., Zawia, N. H., & Barone, S. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(00)00008-5 · Cited by 62 · see citing works

Specificity Protein 1 (Sp1) Maintains Basal Epithelial Expression of the miR-200 Family

Kolesnikoff, N., Attema, J. L., Roslan, S., Bert, A. G., Schwarz, Q., Gregory, P. A., & Goodall, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529172 · Cited by 60 · see citing works

Transcription factor Sp1 is expressed by three different developmentally regulated messenger ribonucleic acids in mouse spermatogenic cells

Persengiev, S. P., Raval, P., Rabinovitch, S., Millette, C. F., & Kilpatrick, D. L. (1996) · Endocrinology · doi:10.1210/en.137.2.638 · Cited by 60 · see citing works

Regulation of constitutive expression of mouse PTEN by the 5′-untranslated region

Han, B., Dong, Z., Liu, Y., Chen, Q., Hashimoto, K., & Zhang, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206783 · Cited by 58 · see citing works

p53-Dependent Transcriptional Control of Cellular Prion by Presenilins

Vincent, B., Sunyach, C., Orzechowski, H., George‐Hyslop, P. S., & Checler, F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0789-09.2009 · Cited by 56 · see citing works

Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer

Ramaiah, M. J., Naushad, S. M., Ponnusamy, L., Arivazhagan, G., Sakthiprasad, V., & Pal‐Bhadra, M. (2017) · Gene · doi:10.1016/j.gene.2017.10.018 · Cited by 57 · see citing works

p53 down‐regulates matrix metalloproteinase‐1 by targeting the communications between AP‐1 and the basal transcription complex

Sun, Y., Zeng, X., Wenger, L., Firestein, G. S., & Cheung, H. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20044 · Cited by 57 · see citing works

A comprehensive study of p53 protein

Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 55 · see citing works

Sp1-p53 Heterocomplex Mediates Activation of HTLV-I Long Terminal Repeat by 12-O-Tetradecanoylphorbol-13-acetate That Is Antagonized by Protein Kinase C

Torgeman, A., Mor‐Vaknin, N., Zelin, E., Ben-Aroya, Z., Löchelt, M., Flügel, R. M., & Aboud, M. (2001) · Virology · doi:10.1006/viro.2000.0779 · Cited by 54 · see citing works

RelA-Associated Inhibitor Blocks Transcription of Human Immunodeficiency Virus Type 1 by Inhibiting NF-κB and Sp1 Actions

Takada, N., Sanda, T., Okamoto, H., Yang, J., Asamitsu, K., Sarol, L. D. C., Kimura, G., Uranishi, H., Tetsuka, T., & Okamoto, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8019-8030.2002 · Cited by 53 · see citing works

Transcriptional Repression of Protein Kinase Cα via Sp1 by Wild Type p53 Is Involved in Inhibition of Multidrug Resistance 1 P-Glycoprotein Phosphorylation

Zhan, M., Yu, D., Liu, J., Hannay, J. A. F., & Pollock, R. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407450200 · Cited by 52 · see citing works

Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter

Benoît, V., Hellin, A., Huygen, S., GIELEN, J. E., Bours, V., & Merville, M.-P. (2000) · Oncogene · doi:10.1038/sj.onc.1203831 · Cited by 52 · see citing works

Epidermal Growth Factor Sensitizes Cells to Ionizing Radiation by Down-regulating Protein Mutated in Ataxia-Telangiectasia

Gueven, N., Keating, K. E., Chen, P., Fukao, T., Khanna, K. K., Watters, D. J., Rodemann, H. P., & Lavin, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006190200 · Cited by 51 · see citing works

Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene

Kelavkar, U. P., & Badr, K. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4378 · Cited by 49 · see citing works

A Comparison of Apoptosis and Necrosis Induced by Hepatotoxins in HepG2 Cells

O’Brien, T. J., Babcock, G. F., Cornelius, J. R., Dingeldein, M., Talaska, G., Warshawsky, D., & Mitchell, K. R. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8917 · Cited by 49 · see citing works

Regulation of Constitutive Gene Expression through Interactions of Sp1 Protein with the Nuclear Aryl Hydrocarbon Receptor Complex

Wang, F., Wang, W., & Safe, S. H. (1999) · Biochemistry · doi:10.1021/bi982578f · Cited by 49 · see citing works

The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression

van Bodegom, D., Saifudeen, Z. R., Dipp, S., Puri, S., Magenheimer, B. S., Calvet, J. P., & El-Dahr, S. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606510200 · Cited by 46 · see citing works

p53, proto-oncogene and rheumatoid arthritis

Sun, Y., & Cheung, H. S. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.31550 · Cited by 45 · see citing works

Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53

Subler, M. A., Martin, D. W., & Deb, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.103-110.1994 · Cited by 45 · see citing works

BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53

Nie, E., Jin, X., Wu, W., Yu, T., Zhou, X., Zhi, T., Shi, Z., Zhang, J., Liu, N., & You, Y. (2016) · Scientific Reports · doi:10.1038/srep39743 · Cited by 44 · see citing works

Induction of Apoptosis in Glioblastoma Cells by Inhibition of Protein Kinase C and Its Association with the Rapid Accumulation of p53 and Induction of the Insulin-like Growth Factor-1-Binding Protein-3

Shen, L., & Glazer, R. I. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00045-8 · Cited by 39 · see citing works

The NF-Y/p53 liaison: Well beyond repression

Imbriano, C., Gnesutta, N., & Mantovani, R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.001 · Cited by 38 · see citing works

Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells

Cheng, Y.-H., Chang, L. W., & Tsou, T. (2005) · Archives of Toxicology · doi:10.1007/s00204-005-0045-1 · Cited by 38 · see citing works

Regulation of p53 mediated transactivation by the β‐subunit of protein kinase CK2

Schuster, N., Prowald, A., Schneider, E., Scheidtmann, K., & Montenarh, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00273-2 · Cited by 37 · see citing works

A Proliferative p53-Responsive Element Mediates Tumor Necrosis Factor Alpha Induction of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat

Gualberto, A., Hixon, M. L., Finco, T. S., Perkins, N. D., Nabel, G. J., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3450 · Cited by 37 · see citing works

p53: Its Mutations and Their Impact on Transcription

Vaughan, C. A., Pearsall, I., Yeudall, W. A., Deb, S. P., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_4 · Cited by 35 · see citing works

HPV16 E6 Oncoprotein Stimulates the Transforming Growth Factor-β1 Promoter in Fibroblasts through a Specific GC-Rich Sequence

Dey, A., Atcha, I. A., & Bagchi, S. (1997) · Virology · doi:10.1006/viro.1996.8363 · Cited by 33 · see citing works

E2Fs and the Retinoblastoma Protein Family

Sardet, C., Cam, L. L., Fabbrizio, E., & Vidal, M. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8934-6_1 · Cited by 33 · see citing works

Tissue-specific p53 expression in the nervous system

Tendler, Y., Weisinger, G., Coleman, R., Diamond, E., Lischinsky, S., Kerner, H., Rotter, V., & Zinder, O. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00202-8 · Cited by 32 · see citing works

Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific Manner

Hudson, J. M., Frade, R., & Bar‐Eli, M. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.759 · Cited by 29 · see citing works

Transcriptional involvement in neurotoxicity

Zawia, N. H. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00161-3 · Cited by 29 · see citing works

The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer Therapy

Milosavljević, V., Haddad, Y., Rodrigo, M. Á. M., Moulick, A., Polanska, H. H., Hynek, D., Heger, Z., Kopel, P., & Adam, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163983 · Cited by 28 · see citing works

Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line

Srinivasa, S. P., & Doshi, P. D. (2002) · Leukemia · doi:10.1038/sj.leu.2402367 · Cited by 52 · see citing works

Transforming growth factor-β1 augments granulocyte-macrophage colony-stimulating factor–induced proliferation of umbilical cord blood CD34+ cells with an associated tyrosine phosphorylation of STAT5

Suzuki, M., Harashima, A., Okochi, A., Yamamoto, M., Matsuo, Y., Motoda, R., Yoshioka, T., & Orita, K. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00902-5 · Cited by 9 · see citing works

Sp1 Plays a Critical Role in the Transcriptional Activation of the Human Cyclin-dependent Kinase Inhibitor p21 Gene by the p53 Tumor Suppressor Protein

Koutsodontis, G., Tentes, I. K., Papakosta, P., Moustakas, A., & Kardassis, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104130200 · Cited by 159 · see citing works

The Tumor Suppressor Gene p53 Can Mediate Transforming The Growth Factor 31-induced Differentiation of Leukemic Cells Independently of Activation of the

Protein, R., Gullberg, U., & Olsson, I. (2015)

STUDY OF THE INTERACTION BETWEEN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND S100P PROTEIN ON THE MONOCYTIC LEUKEMIA CELL LINE THP-1

Bobrova, L. A., & Zemskova, M. Y. (2024) · Высшая школа: научные исследования · doi:10.25205/978-5-4437-1691-6-221